Industrial nuclease for fragmenting residual DNA and RNA to improve process fluid behavior before clarification, filtration, centrifugation, chromatography, and related bioseparation steps.
Request pricingLong residual DNA and RNA can change how a biological process stream behaves. Even when nucleic acids are not the primary product or impurity of interest, they can increase viscosity, hold fine solids in suspension, contribute to turbidity, complicate phase separation, and make downstream unit operations less predictable.
Strandfall supplies Nuclease (DNA/RNA-Degrading Enzyme) for B2B process teams that need controlled nucleic acid fragmentation before clarification, filtration, centrifugation, chromatography, or other bioseparation steps.
The purpose is practical: shorten nucleic acid chains so the process fluid handles more cleanly.
Nuclease is commonly evaluated when nucleic-acid-driven fluid behavior creates friction around upstream or intermediate recovery steps.
Typical integration points include:
Strandfall nuclease is not positioned as a generic lab reagent. It is supplied for controlled manufacturing and development environments where documentation, supply continuity, and lot-to-lot confidence matter.
Nuclease fragments DNA and RNA into shorter nucleic acid pieces, supporting residual nucleic acid reduction strategies and making streams easier to prepare for downstream purification.
When long nucleic acids contribute to haze, fine-particle suspension, or difficult solids removal, nuclease treatment can help move the stream toward more manageable clarification behavior.
Shorter nucleic acid fragments can reduce polymer-driven resistance in filtration trains, helping teams address slow throughput, premature fouling, and inconsistent filter performance.
Clarified or conditioned feeds with lower long-chain nucleic acid content are often easier to evaluate for chromatography, membrane operations, concentration, and polishing steps.
Process enzymes are part of the control strategy. Strandfall supports procurement teams with consistent supply handling, fit-for-purpose documentation, and clear specification alignment without exposing trader-confidential activity methods.
Harvest fluids may contain host-cell nucleic acids released during culture stress, shear, or processing. Nuclease can be assessed as a conditioning step to reduce long-chain DNA/RNA effects before clarification and filtration.
Lysis can release dense nucleic acid loads that create viscosity and handling issues. Nuclease treatment can support smoother transfer, mixing, centrifugation, and primary recovery behavior.
In workflows where residual nucleic acids must be controlled without destabilizing the broader process, nuclease may support feed preparation ahead of filtration or bioseparation steps.
Where nucleic acids are process-related impurities rather than target molecules, nuclease treatment can help improve material handling before capture or polishing.
To quote accurately and support technical fit, Strandfall typically asks for process context rather than academic detail.
Useful inputs include:
Every process stream is different. The best nuclease evaluation focuses on measurable operational endpoints rather than enzyme addition alone.
Recommended evaluation endpoints may include:
Strandfall can support specification discussion and procurement planning while your technical team defines the process window internally.
Tell us what stream you are treating and which unit operation you need to protect. Strandfall will respond with supply options, documentation availability, and pricing guidance for nuclease used in clarification, filtration, or bioseparation support.



Tell us your application and volume — we reply with pricing and lead time.